Globally, a staggering 310 million major surgeries are performed annually—around 40 to 50 million in the US and 20 million in Europe. The growing number of surgeries can be attributed to the rapidly growing senior population worldwide and the increasing prevalence of chronic diseases. Apart from the rising geriatric population, the prevalence of lifestyle disorders such as cardiac diseases, diabetes, hypertension, obesity, and cancer is also increasing globally—not only among the elderly but also among younger people.
With the rise in the overall number of such surgeries performed globally, the demand for anastomosis devices is also set to rise. These devices aid in faster recovery, minimal scarring, and reduced blood loss.
The high prices of these devices further escalate the cost of surgical procedures. Since healthcare providers are increasingly focusing on curbing healthcare costs and reducing the cost burden on patients, the high cost of surgical staplers is expected to limit their demand to a certain extent, especially in developing countries.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=5343963
Emerging economies such as India, South Korea, Malaysia, Vietnam, Africa, and Middle Eastern countries such as Israel, Saudi Arabia, and the UAE offer significant growth opportunities to major market players. This can be attributed to their low regulatory barriers, improvements in healthcare infrastructure, growing patient population, and rising healthcare expenditure.
In addition, the regulatory policies in the Asia Pacific region are more adaptive and business-friendly than those in developed countries. This, along with the increasing competition in mature markets, has drawn key players in the anastomosis devices market to focus on emerging countries.
[305 Pages Report] The global anastomosis device market is projected to reach USD 4.4 billion by 2027 from USD 3.0 billion in 2022, at a CAGR of 8.3% during the forecast period. Growth in this market is mostly driven by the increasing incidence of target diseases and the subsequent growth in the number of surgical procedures, the growing demand for minimally invasive surgeries, and technological advancements.
The anastomosis device market is highly consolidated. The top players in this market Johnson Johnson (US), Medtronic Plc (Ireland), B. Braun Melsungen (Germany), Intuitive Surgical Inc. (US), Boston Scientific Corporation (US), and Artivion, Inc. (US). These players lead the market because of their extensive product portfolios and a wide geographic presence.
The anastomosis device market has been segmented into cardiovascular thoracic surgery, gastrointestinal surgery, orthopaedic surgery, gynaecological surgery, and other applications. In 2021, the cardiovascular thoracic surgery segment accounted for the largest share of the anastomosis device market. Rising incidence of cardiovascular thoracic diseases and the extensive usage of anastomosis devices in these surgical procedures is driving the growth of this segment.
